Maplelane Capital, LLC Ligand Pharmaceuticals Inc Put Options Transaction History

Maplelane Capital, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $9.67 Million - $12.7 Million	120,000 Added 80.0%	270,000 $26.9 Million
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $2.69 Million - $3.8 Million	30,000 Added 25.0%	150,000 $14.3 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $7.51 Million - $13.6 Million	-110,000 Reduced 47.83%	120,000 $13.4 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $4.12 Million - $7.01 Million	65,000 Added 39.39%	230,000 $16.7 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $12.1 Million - $14.2 Million	-125,000 Reduced 43.1%	165,000 $17.2 Million
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $25 Million - $34.8 Million	290,000 New	290,000 $28.9 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $37.1 Million - $49.9 Million	-350,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $44.9 Million - $95.2 Million	350,000 New	350,000 $47.5 Million

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Maplelane Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Maplelane Capital, LLC with notifications on news.